IRIS Institutional Research Information System - OPENBS Open Archive UniBS

ALTOMARE, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 166
EU - Europa 90
AS - Asia 33
AF - Africa 1
SA - Sud America 1
Totale 291
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 166
DE - Germania 36
CN - Cina 21
IT - Italia 14
UA - Ucraina 12
RU - Federazione Russa 8
GB - Regno Unito 7
IN - India 7
HK - Hong Kong 4
FI - Finlandia 3
IE - Irlanda 2
PT - Portogallo 2
BE - Belgio 1
EC - Ecuador 1
FR - Francia 1
KG - Kirghizistan 1
LV - Lettonia 1
MA - Marocco 1
NO - Norvegia 1
PL - Polonia 1
SE - Svezia 1
Totale 291
Salva come PNG Salva come JPEG
Città #
Fairfield 32
Woodbridge 21
Houston 17
Ashburn 12
Jacksonville 10
Wilmington 10
Seattle 9
Cambridge 8
New York 8
Chandler 7
Mumbai 7
Beijing 6
Dearborn 5
Hong Kong 4
Nanjing 4
Princeton 4
Ann Arbor 3
Bergamo 3
Helsinki 3
Jinan 3
Padova 3
Des Moines 2
Dublin 2
Nürnberg 2
Palermo 2
San Diego 2
San Francisco 2
Shanghai 2
Venice 2
Augusta 1
Bishkek 1
Bologna 1
Brescia 1
Brussels 1
Changsha 1
Guayaquil 1
Hangzhou 1
Hebei 1
Kunming 1
Lisbon 1
Los Angeles 1
Nanchang 1
Oslo 1
Philadelphia 1
Rabat 1
Riga 1
Stockholm 1
Tianjin 1
Walnut 1
Washington 1
Totale 216
Salva come PNG Salva come JPEG
Nome #
Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation 140
Do Beliefs about the Pathogenetic Role of Amyloid Affect the Interpretation of Amyloid PET in the Clinic. 127
Comparison of visual criteria for amyloid-pet reading: Could criteria merging reduce inter-rater variability? 10
Plasma biomarkers for Alzheimer's disease: A field-test in a memory clinic 4
Neuropsychiatric Symptoms in Frontotemporal Dementia: More Than Just Noise? 4
Home-based transcranial alternating current stimulation (tACS) in Alzheimer’s disease: rationale and study design 3
Applying the ATN scheme in a memory clinic population: The ABIDE project 3
Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington’s disease 2
Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia 2
Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia 2
European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus 2
Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe 2
Accuracy and reproducibility of automated white matter hyperintensities segmentation with lesion segmentation tool: A European multi-site 3T study 2
Quantitative appraisal of the Amyloid Imaging Taskforce appropriate use criteria for amyloid-PET 2
Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders 2
Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia 2
Prognostic value of Alzheimer’s biomarkers in mild cognitive impairment: the effect of age at onset 2
Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services—part 4 of 6 1
AMYPAD Diagnostic and Patient Management Study: Rationale and design 1
Brain connectivity and metacognition in persons with subjective cognitive decline (COSCODE): rationale and study design 1
Diagnostic value of amyloid-PET and tau-PET: a head-to-head comparison 1
Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer’s disease 1
The amyloid imaging for the prevention of Alzheimer's disease consortium: A European collaboration with global impact 1
Brain atrophy in Alzheimer's Disease and aging 1
Clinical applicability of quantitative atrophy measures on MRI in patients suspected of Alzheimer’s disease 1
The Clinical Use of Alzheimer's Disease Biomarkers in Patients with Mild Cognitive Impairment: A European Alzheimer's Disease Consortium Survey 1
Societal and equity challenges for Brain Health Services. A user manual for Brain Health Services—part 6 of 6 1
Feasibility of a standard cognitive assessment in European academic memory clinics 1
Recruitment of pre-dementia participants: main enrollment barriers in a longitudinal amyloid-PET study 1
Precision prevention of Alzheimer's and other dementias: Anticipating future needs in the control of risk factors and implementation of disease-modifying therapies 1
Analysis of Psychological Symptoms Following Disclosure of Amyloid-Positron Emission Tomography Imaging Results to Adults with Subjective Cognitive Decline 1
Quantification of [18F]florbetaben amyloid-PET imaging in a mixed memory clinic population: The ABIDE project 1
Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study 1
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum 1
Outcomes of clinical utility in amyloid-PET studies: state of art and future perspectives 1
Protocols for cognitive enhancement. A user manual for Brain Health Services—part 5 of 6 1
The probabilistic model of Alzheimer disease: the amyloid hypothesis revised 1
Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services—part 2 of 6 1
Clinical utility of FDG-PET for the clinical diagnosis in MCI 1
Dementia risk communication. A user manual for Brain Health Services—part 3 of 6 1
Medial temporal lobe atrophy and posterior atrophy scales normative values 1
Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical Trial 1
Description of a European memory clinic cohort undergoing amyloid-PET: The AMYPAD Diagnostic and Patient Management Study 1
Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer’s disease 1
Multitracer model for staging cortical amyloid deposition using PET imaging 1
Comment: Is a Large-Scale Screening for Alzheimer's Disease Possible? Yes, in a Few Years 1
Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia 1
Time to Diagnosis and Its Predictors in Syndromes Associated With Frontotemporal Lobar Degeneration 1
Brain Health Services: organization, structure, and challenges for implementation. A user manual for Brain Health Services—part 1 of 6 1
Dementia prevention in memory clinics: recommendations from the European task force for brain health services 1
Totale 344
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.407
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.407
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201922 0 0 0 0 0 0 0 0 0 0 11 11
2019/202090 12 4 5 10 6 12 10 9 7 9 2 4
2020/202144 0 10 11 3 2 2 2 3 3 3 4 1
2021/202222 1 0 1 2 0 0 1 2 5 2 2 6
2022/202316 3 1 0 3 1 5 0 0 3 0 0 0
2023/2024100 3 2 7 0 0 11 2 1 5 55 14 0
Totale 344